not trying to be a rah rah guy, but doesnt anyone else agree that JR stepping down might be a good thing?
1. He was not a polished CEO and maybe now that they are uplisted and part of several indexes, the company needs a CEO that is polished and can talk to investors and analysts at the right level
2. we need someone running the company that truly knows how to run a pharmaceutical company
News 
Market Data 
Discover 
